keyword
https://read.qxmd.com/read/38528631/head-and-neck-cancer-of-unknown-primary-unveiling-primary-tumor-sites-through-machine-learning-on-dna-methylation-profiles
#1
JOURNAL ARTICLE
Leonhard Stark, Atsuko Kasajima, Fabian Stögbauer, Benedikt Schmidl, Jakob Rinecker, Katharina Holzmann, Sarah Färber, Nicole Pfarr, Katja Steiger, Barbara Wollenberg, Jürgen Ruland, Christof Winter, Markus Wirth
BACKGROUND: The unknown tissue of origin in head and neck cancer of unknown primary (hnCUP) leads to invasive diagnostic procedures and unspecific and potentially inefficient treatment options for patients. The most common histologic subtype, squamous cell carcinoma, can stem from various tumor primary sites, including the oral cavity, oropharynx, larynx, head and neck skin, lungs, and esophagus. DNA methylation profiles are highly tissue-specific and have been successfully used to classify tissue origin...
March 25, 2024: Clinical Epigenetics
https://read.qxmd.com/read/38458037/clinical-features-and-prognostic-factors-of-nasopharyngeal-carcinoma-with-brain-metastases
#2
JOURNAL ARTICLE
Kehui Chen, Mengting Shi, Silang Mo, Tingting Liu, Yuanyuan Zhao, Li Zhang, Shen Zhao
BACKGROUND: Brain metastasis in nasopharyngeal carcinoma is a rare occurrence, and the characteristics of patients in this subgroup remain poorly defined. This study aims to delineate the clinical features, treatment modalities, prognostic factors, and survival of nasopharyngeal carcinoma patients with brain metastasis. METHODOLOGY: A retrospective analysis was conducted on patients diagnosed with nasopharyngeal carcinoma who developed brain metastasis and were treated at the Sun Yat-sen University Cancer Center between July 2000 and July 2023...
March 7, 2024: Oral Oncology
https://read.qxmd.com/read/38429970/dual-role-of-grhl3-in-bladder-carcinogenesis-depending-on-histological-subtypes
#3
JOURNAL ARTICLE
Franziska C Lammert, Julia Pannhausen, Erik Noetzel, Florian Friedland, Julia Wirtz, Yannick Herfs, Sophie Leypold, Lin Gan, Ralf Weiskirchen, Tician Schnitzler, Ruth Knüchel, Jochen Maurer, Danny D Jonigk, Michael Rose, Nadine T Gaisa
The effect of grainyhead-like transcription factor 3 (GRHL3) on cancer development depends on the cancer subtypes as shown in tumor entities such as colorectal or oral squamous cell carcinomas. Here, we analyzed the subtype-specific role of GRHL3 in bladder carcinogenesis, comparing common urothelial carcinoma (UC) with squamous bladder cancer (sq-BLCA). We examined GRHL3 mRNA and protein expression in cohorts of patient samples, its prognostic role and its functional impact on tumorigeneses in different molecular and histopathological subtypes of bladder cancer...
March 2, 2024: Molecular Oncology
https://read.qxmd.com/read/38415269/primary-malignant-melanoma-of-the-endometrium-a-case-report
#4
Xiuting Shi, Jie Shi, Yanli Li, Xin Li, Xuemei Hu, Han Gao
INTRODUCTION: Malignant melanoma most commonly occurs in the skin. Primary malignant melanoma of endometrium is quite rare. Its diagnosis depends on clinical characteristics and pathological examination. It usually exhibits high degree of tumor histology, early onset of distant metastases, and unfavorable prognoses. CASE PRESENTATION: In this paper, we report a case of a 73-year-old woman with primary malignant melanoma of endometrium. This patient denied a history of nevus removal or any family medical history of cancer...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38219707/molecular-subtyping-of-head-and-neck-cancer-clinical-applicability-and-correlations-with-morphological-characteristics
#5
JOURNAL ARTICLE
Fabian Stögbauer, Raik Otto, Korinna Jöhrens, Ingeborg Tinhofer, Ulrich Keilholz, Christopher Poremba, Ulrich Keller, Ulf Leser, Wilko Weichert, Melanie Boxberg, Konrad Klinghammer
AIM: We aimed to evaluate the applicability of a customized NanoString panel for molecular subtyping of recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Additionally, histological analyses were conducted, correlated with the molecular subtypes and tested for their prognostic value. MATERIAL AND METHODS: We conducted molecular subtyping of R/M-HNSCC according to the molecular subtypes defined by Keck et al. For molecular analyses a 231 gene customized NanoString panel (the most accurately subtype defining genes, based on previous analyses) was applied to tumor samples from R/M-HNSCC patients that were treated in the CeFCiD trial (AIO/IAG-KHT trial 1108)...
January 13, 2024: Oral Oncology
https://read.qxmd.com/read/38211606/optimising-first-line-subtyping-based-therapy-in-triple-negative-breast-cancer-future-super-a-multi-cohort-randomised-phase-2-trial
#6
RANDOMIZED CONTROLLED TRIAL
Lei Fan, Zhong-Hua Wang, Lin-Xiaoxi Ma, Song-Yang Wu, Jiong Wu, Ke-Da Yu, Xin-Yi Sui, Ying Xu, Xi-Yu Liu, Li Chen, Wen-Juan Zhang, Xi Jin, Qin Xiao, Ruo-Hong Shui, Yi Xiao, Han Wang, Yun-Song Yang, Xiao-Yan Huang, A-Yong Cao, Jun-Jie Li, Gen-Hong Di, Guang-Yu Liu, Wen-Tao Yang, Xin Hu, Yan Xia, Qian-Nan Liang, Yi-Zhou Jiang, Zhi-Ming Shao
BACKGROUND: Triple-negative breast cancers display heterogeneity in molecular drivers and immune traits. We previously classified triple-negative breast cancers into four subtypes: luminal androgen receptor (LAR), immunomodulatory, basal-like immune-suppressed (BLIS), and mesenchymal-like (MES). Here, we aimed to evaluate the efficacy and safety of subtyping-based therapy in the first-line treatment of triple-negative breast cancer. METHODS: FUTURE-SUPER is an ongoing, open-label, randomised, controlled phase 2 trial being conducted at Fudan University Shanghai Cancer Center (FUSCC), Shanghai, China...
February 2024: Lancet Oncology
https://read.qxmd.com/read/38193945/comparative-e-cadherin-and-syndecan-1-protein-expression-in-human-and-canine-oral-squamous-cell-carcinoma
#7
JOURNAL ARTICLE
Sirinun P Tabtieang, Weejarin Paphussaro, Anudep Rungsipipat, Nanthida Kunnasut, Sekkarin Ploypetch, Ekarat Phattarataratip, Gunnaporn Suriyaphol
Oral squamous cell carcinoma (OSCC) is a prevalent form of oral cancer in humans and dogs. The altered expression of cell adhesion molecules, including E-cadherin (CDH1) and syndecan-1 (SDC1), is involved in cancer progression. This study aimed to investigate the protein expression of CDH1 and SDC1 in early and late clinical stages of human and canine OSCC (hOSCC and cOSCC, respectively), using immunohistochemistry. Formalin-fixed and paraffin embedded tissue blocks were obtained from 21 hOSCC, 8 human normal gingiva, 26 cOSCC, and 13 canine normal gingiva...
January 9, 2024: Acta Veterinaria Hungarica
https://read.qxmd.com/read/38016228/her2-targeted-therapies-for-salivary-gland-cancers
#8
REVIEW
Daria Maria Filippini, Rachele Pagani, Nastassja Tober, Luigi Lorini, Mattia Riefolo, Giulia Molinari, Arianna Burato, Salvatore Alfieri, Paolo Bossi, Livio Presutti
Salivary gland cancers (SGCs) are a heterogeneous group of rare tumors including various histological subtypes with different molecular profiling. Human epidermal growth factor receptor 2 (HER2) is one of the most intriguing and studied molecular alterations with prognostic and predictive roles. Indeed, HER2 overexpression is commonly correlated with aggressive histological subtypes and poorer prognosis. However, HER2 may represent the target of personalized treatment. We performed a literature review of use of anti-HER2 targeted agents for treatment of recurrent or metastatic SGCs...
November 27, 2023: Oral Oncology
https://read.qxmd.com/read/37915680/reconstructive-surgery-and-adjuvant-radiotherapy-for-the-multimodal-approach-in-oral-cancer-a-single-cancer-centre-experience
#9
JOURNAL ARTICLE
Wilber Edison Bernaola-Paredes, Monica Lucia Rodrigues, Henrique Perez Carvalho, Fernando Dos Santos Bitencourt, Marcelo Carvalho Coutinho, Felipe D'Almeida Costa, Kleber Arturo Vallejo-Rosero, Jose Agustin Marquez-Zambrano, Antonio Cassio Assis Pellizzon
INTRODUCTION AND IMPORTANCE: Ablative surgery for oral cancer, irrespective of the histological subtype, causes large tissue defects, functional and aesthetic damage. Microsurgical free flaps have been widely used in reconstruction after resection, with satisfactory success rates in conjunction with adjuvant radiotherapy (RT). This study aims to describe our clinical institutional experience based on the multimodal treatment performed in four cases diagnosed with oral squamous cell carcinoma with the use of different microvascular free flaps and RT...
November 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37890493/spatiotemporal-genomic-profiling-of-intestinal-metaplasia-reveals-clonal-dynamics-of-gastric-cancer-progression
#10
JOURNAL ARTICLE
Kie Kyon Huang, Haoran Ma, Roxanne Hui Heng Chong, Tomoyuki Uchihara, Benedict Shi Xiang Lian, Feng Zhu, Taotao Sheng, Supriya Srivastava, Su Ting Tay, Raghav Sundar, Angie Lay Keng Tan, Xuewen Ong, Minghui Lee, Shamaine Wei Ting Ho, Tom Lesluyes, Hassan Ashktorab, Duane Smoot, Peter Van Loo, Joy Shijia Chua, Kalpana Ramnarayanan, Louis Ho Shing Lau, Takuji Gotoda, Hyun Soo Kim, Tiing Leong Ang, Christopher Khor, Jonathan Wei Jie Lee, Stephen Kin Kwok Tsao, Wei Lyn Yang, Ming Teh, Hyunsoo Chung, Jimmy Bok Yan So, Khay Guan Yeoh, Patrick Tan
Intestinal metaplasia (IM) is a pre-malignant condition of the gastric mucosa associated with increased gastric cancer (GC) risk. Analyzing 1,256 gastric samples (1,152 IMs) across 692 subjects from a prospective 10-year study, we identify 26 IM driver genes in diverse pathways including chromatin regulation (ARID1A) and intestinal homeostasis (SOX9). Single-cell and spatial profiles highlight changes in tissue ecology and IM lineage heterogeneity, including an intestinal stem-cell dominant cellular compartment linked to early malignancy...
October 20, 2023: Cancer Cell
https://read.qxmd.com/read/37886165/planned-drug-holidays-during-treatment-with-lenvatinib-for-radioiodine-refractory-differentiated-thyroid-cancer-a-retrospective-study
#11
JOURNAL ARTICLE
Chihiro Matsuyama, Tomohiro Enokida, Yuri Ueda, Shinya Suzuki, Takao Fujisawa, Kazue Ito, Susumu Okano, Makoto Tahara
BACKGROUND: In the phase 3 SELECT study, lenvatinib significantly improved prognostic outcomes vs. placebo in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). However, toxicity of lenvatinib is sometimes considerable and requires frequent dose interruptions and modifications. Recently, planned drug holidays have been proposed as a means of avoiding severe adverse events (AEs). METHODS: We retrospectively reviewed medical records to compare the efficacy and safety of lenvatinib in RR-DTC patients who underwent planned drug holidays (planned holiday group) vs...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37684354/axitinib-in-patients-with-advanced-metastatic-soft-tissue-sarcoma-axi-sts-an-open-label-multicentre-phase-ii-trial-in-four-histological-strata
#12
MULTICENTER STUDY
Penella J Woll, Piers Gaunt, Charlotte Gaskell, Robin Young, Charlotte Benson, Ian R Judson, Beatrice M Seddon, Maria Marples, Nasim Ali, Sandra J Strauss, Alexander Lee, Ana Hughes, Baljit Kaur, David Hughes, Lucinda Billingham
BACKGROUND: Axitinib is an oral vascular endothelial growth factor receptor inhibitor with anti-tumour activity in renal, thyroid, and pancreatic cancer. METHODS: Axi-STS was a pathologically-stratified, non-randomised, open-label, multi-centre, phase II trial of continuous axitinib treatment in patients ≥16 years, performance status ≤2, with pathologically-confirmed advanced/metastatic soft tissue sarcoma (STS). Patients were recruited within four tumour strata, each analysed separately: angiosarcoma, leiomyosarcoma, synovial sarcoma, or other eligible STSs...
October 2023: British Journal of Cancer
https://read.qxmd.com/read/37588336/clinicopathological-parameters-and-biomarker-profile-in-a-cohort-of-patients-with-head-and-neck-squamous-cell-carcinoma-hnscc
#13
JOURNAL ARTICLE
Atif A Hashmi, Ummara Bukhari, Mahnoor Aslam, Rana Sajawal Joiya, Ravi Kumar, Umair Arshad Malik, Shamail Zia, Abdur Rahim Khan, Mubasshir Saleem, Muhammad Irfan
INTRODUCTION:  Squamous cell carcinoma (SCC) is the most common malignancy of the head and neck region, commonly termed as head and neck squamous cell carcinoma (HNSCC). Data related to biomarker expression in HNSCC are scarcely available, especially in our population. This study aimed to evaluate the association of immunohistochemical (IHC) expression of p16, epidermal growth factor receptor (EGFR), p27, and p53 in HNSCC with clinical and pathological parameters. METHODS:  This retrospective cross-sectional study was conducted at the Department of Histopathology, Liaquat National Hospital, Karachi, Pakistan from February 2017 to January 2022...
July 2023: Curēus
https://read.qxmd.com/read/37563059/progression-to-malignancy-in-oral-potentially-malignant-disorders-a-retrospective-study-of-5-036-patients-in-ontario-canada
#14
JOURNAL ARTICLE
Christina McCord, Paulina Achita, Alex Kiss, Marco A Magalhaes, Mark Darling, Grace Bradley
OBJECTIVES: Determine the rate of malignant transformation (MT) of oral potentially malignant disorders (OPMDs) and risk factors for transformation. STUDY DESIGN: The OPMD database (2001-2015) from 2 biopsy services in Ontario, Canada, was linked to the Ontario Cancer Registry to determine the rate of progression to oral squamous cell carcinoma (OSCC). Clinical and histologic features of progressed and non-progressed cases were compared to determine risk factors for progression...
October 2023: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
https://read.qxmd.com/read/37523661/characterization-and-management-of-adverse-reactions-in-patients-with-advanced-endometrial-cancer-receiving-lenvatinib-plus-pembrolizumab
#15
JOURNAL ARTICLE
Nicoletta Colombo, Domenica Lorusso, Bradley J Monk, Brian Slomovitz, Kosei Hasegawa, Angélica Nogueira-Rodrigues, Melissa Zale, Chinyere E Okpara, Gianmaria Barresi, Jodi McKenzie, Vicky Makker
BACKGROUND: Lenvatinib plus pembrolizumab significantly improved efficacy compared with chemotherapy in patients with advanced endometrial cancer (aEC) regardless of microsatellite instability status or histologic subtype, who had disease progression following prior platinum-based therapy, in Study-309/KEYNOTE-775. The safety profile of the combination was generally consistent with that of each monotherapy drug and of the combination in patients with endometrial cancer and other solid tumors...
July 31, 2023: Oncologist
https://read.qxmd.com/read/37485190/clinicopathological-parameters-predicting-nodal-metastasis-in-head-and-neck-squamous-cell-carcinoma
#16
JOURNAL ARTICLE
Atif A Hashmi, Rutaba Tola, Khushbakht Rashid, Abrahim H Ali, Tanim Dowlah, Umair Arshad Malik, Shamail Zia, Mubasshir Saleem, Fnu Anjali, Muhammad Irfan
Introduction Squamous cell carcinoma (SCC) is the most common type of malignancy of the head and neck region arising from the mucosal epithelium of the oral cavity and oropharynx. It is a multifactorial disease with a high rate of mortality. Lymph node metastasis is an important prognostic parameter associated with adverse prognosis. This study was conducted to establish a relationship between various clinicopathological characteristics and nodal metastasis in head and neck squamous cell carcinoma (HNSCC)...
June 2023: Curēus
https://read.qxmd.com/read/37016270/alveolar-rhabdomyosarcoma-has-superior-response-rates-to-vinorelbine-compared-to-embryonal-rhabdomyosarcoma-in-patients-with-relapsed-refractory-disease-a-meta-analysis
#17
JOURNAL ARTICLE
Wendy Allen-Rhoades, Philip J Lupo, Michael E Scheurer, Yueh-Yun Chi, John F Kuttesch, Rajkumar Venkatramani, William H Meyer, Leo Mascarenhas
BACKGROUND: Patients with alveolar rhabdomyosarcoma (ARMS) have inferior outcomes compared to patients with embryonal rhabdomyosarcoma (ERMS) and more effective chemotherapy options are needed for these patients. Vinorelbine is a semisynthetic vinca alkaloid that has clinical activity in relapsed rhabdomyosarcoma (RMS) when used alone or in combination with cyclophosphamide. AIMS: The goal of our study was to evaluate whether RMS histology subtype influences response rate to vinorelbine alone or in combination...
April 4, 2023: Cancer Medicine
https://read.qxmd.com/read/36789760/stratifying-the-risk-of-ovarian-cancer-incidence-by-histologic-subtypes-in-the-korean-epithelial-ovarian-cancer-study-ko-eve
#18
JOURNAL ARTICLE
Soseul Sung, Youjin Hong, Byoung-Gie Kim, Ji-Yeob Choi, Jae Weon Kim, Sang-Yoon Park, Jae-Hoon Kim, Yong-Man Kim, Jong-Min Lee, Tae Jin Kim, Sue K Park
INTRODUCTION: This study aimed to verify the association between ovarian cancer (OC) and reproductive- and lifestyle-related risk factors stratified by the subtype of OC. METHODS: In this matched case-control study derived from the Korean epithelial ovarian cancer study (Ko-EVE), we calculated the risk of OC subtypes using odds ratios (ORs) and 95% confidence intervals (95% CIs) in a logistic regression model. RESULTS: As a result of matching, 531 cases and 2,124 controls were selected...
February 15, 2023: Cancer Medicine
https://read.qxmd.com/read/36781109/a-nomogram-for-predicting-survival-in-patients-with-oral-tongue-keratinized-squamous-cell-carcinoma-a-seer-based-study
#19
JOURNAL ARTICLE
Zishun Qin, Zonghao Hu, Minqin Lai, Feng Wang, Xiaoyuan Liu, Lihua Yin
OBJECTIVE: Oral tongue keratinized squamous cell carcinoma (OTKSCC), a relatively rare form of tongue cancer (TC) in clinical practice, accompanied by features of cell keratosis, is an uncommon histological subtype. However, its specific clinicopathological features and prognosis have not been adequately described. In this study, we aimed to create a nomogram using R language software to predict overall survival (OS) of patients with OTKSCC to assess the prognosis of OTKSCC patients. METHODS: We extracted clinical and related prognostic data of OTKSCC patients from 1975 to 2019 from the Surveillance, Epidemiology, and End Results database...
February 11, 2023: Journal of Stomatology, Oral and Maxillofacial Surgery
https://read.qxmd.com/read/36756017/role-of-matrix-metalloproteinase-9-in-predicting-lymph-node-metastases-in-oral-squamous-cell-carcinoma
#20
JOURNAL ARTICLE
Satadruti Chakraborty, Turuvekere Narayan Rao Suresh, Azeem S Mohiyuddin
Background Oral cancer is a common malignancy worldwide, with approximately 3,50,000 new cases diagnosed yearly. Out of many factors which affect the survival in patients with oral cancer, lymph node metastases are a major factor that reduces survival by 50%. Even though many biomarkers have been studied to predict lymph node metastasis, none have yet been accepted for routine use. Matrix metalloproteinases (MMPs) play a vital role in extracellular matrix (ECM) degradation, thus facilitating the invasive potential and the metastatic cascade of tumors...
January 2023: Curēus
keyword
keyword
96103
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.